DIT309
/ Fuzhou Tcelltech Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 06, 2026
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Tcelltech Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor
July 07, 2025
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
(clinicaltrials.gov)
- P1 | N=15 | Not yet recruiting | Sponsor: Tcelltech Inc.
New P1 trial • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor
1 to 2
Of
2
Go to page
1